Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 3, 2018Expert Opinion on Drug Metabolism & ToxicologyOpen Access

Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis

View Full Paper
Ask AI
Bookmark
Share

Authors

FBFabio BarraOspedale Policlinico San MartinoCSCarolina ScalaIstituto Giannina GasliniSFSimone FerreroCentre Hospitalier Universitaire de Nice

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barra et al. (2018) studied this question.

synapsesocial.com/papers/6a89c4eea14d41d02f432cb0https://doi.org/10.1080/17425255.2018.1461840
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up2004 · 168 citations
  2. 2Dienogest in the treatment of endometriosis2014 · 74 citations
  3. 3Use of Depot Medroxyprogesterone Acetate and Fracture Risk2010 · 92 citations